Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

BioLabs (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today provided an ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

A tumor marker for pancreatic cancer helps healthcare professionals detect, diagnose, or treat it. However, a person can have high tumor marker levels without having cancer. Tumor markers are ...

Clinical evidence and benefit of special FDA designations in anti-cancer drugs. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text ...

Tumor markers can help doctors diagnose testicular cancer, determine effective treatment, and monitor how well that treatment is working. Doctors have been using tumor markers to help diagnose and ...

A self-propelled nanoparticle engineered through computer simulation could bring laboratory-grade cancer detection to ...

Researchers have modified a unique cancer-loving probiotic bacteria to release a marker that can be detected in the urine after it comes into contact with bowel cancer, even when it's in the early ...